On On December 14th, 2017, Kawin Technology No. 7 Rongchang Street East site was recertified by CFDA GMP for small-volume injection, tablet and capsule.

KW-136 in Combination with Sofosbuvir Under Phase 3 Trial Congratulations to Dr. Yunde Hou, CAS Academician and Founder of Kawin Technology for Winning China’s National Top Science & Technology Prize